Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01899092
What this trial is testing

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Large-scale testing (Phase 3)Study completedNCT01006031
What this trial is testing

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Who this might be right for
Liver CirrhosisHepatitis C VirusHIV Infection
Sociedad Andaluza de Enfermedades Infecciosas 25
Large-scale testing (Phase 3)Study completedNCT01853254
What this trial is testing

Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 272
Not applicableStudy completedNCT02250001
What this trial is testing

Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 2,974
Not applicableStudy completedNCT03373396
What this trial is testing

Impact of Chlordecone on Active Chronic Hepatitis

Who this might be right for
Fibrosis, Liver
Centre Hospitalier Universitaire de la Guadeloupe 283
Testing effectiveness (Phase 2)Study completedNCT00621296
What this trial is testing

Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 15
Testing effectiveness (Phase 2)Study completedNCT01289496
What this trial is testing

Ribavirin Dose Optimization for the Treatment of Hepatitis C

Who this might be right for
Chronic Hepatitis C
Centre hospitalier de l'Université de Montréal (CHUM) 13
Early research (Phase 1)Study completedNCT00343525
What this trial is testing

Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Peregrine Pharmaceuticals 24
Early research (Phase 1)Ended earlyNCT01554085
What this trial is testing

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 78
Not applicableLooking for participantsNCT04525833
What this trial is testing

Liver Disease and Other Systemic Diseases

Who this might be right for
Liver DiseasesHumansProgression+7 more
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 15,000
Early research (Phase 1)Study completedNCT02173574
What this trial is testing

Two-way Interaction Between Alisporivir and EDP239

Who this might be right for
Hepatitis C Virus
Enanta Pharmaceuticals, Inc 42
Testing effectiveness (Phase 2)Study completedNCT01726946
What this trial is testing

Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 10
Not applicableNot Yet RecruitingNCT07503288
What this trial is testing

Genotype and Subtype Mapping of the Hepatitis C Virus

Who this might be right for
Hepatitis C VirusMutation AbnormalityRNA Positive+2 more
Assistance Publique - Hôpitaux de Paris 2,500
Post-approval studies (Phase 4)Study completedNCT03250910
What this trial is testing

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
National Taiwan University Hospital 228
Early research (Phase 1)Study completedNCT03673696
What this trial is testing

The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects

Who this might be right for
Chronic Hepatitis c
Sunshine Lake Pharma Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT01587586
What this trial is testing

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
PharmaEssentia 107
Not applicableStudy completedNCT07702396
What this trial is testing

Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

Who this might be right for
Heptatitis C
Indus Hospital and Health Network 192
Not applicableUnknownNCT03407703
What this trial is testing

Hepatitis C (HCV) Cure and Kidney Health

Who this might be right for
Hepatitis C
San Francisco Veterans Affairs Medical Center 50
Large-scale testing (Phase 3)Study completedNCT01854697
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 311
Not applicableWithdrawnNCT01691235
What this trial is testing

SIMpill Medication Dispensing Device in the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
University of Chicago
Next Page